Page last updated: 2024-11-05

cyanogen bromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyanogen Bromide: Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10476
CHEMBL ID3561885
MeSH IDM0005440

Synonyms (66)

Synonym
wln: e cn
cyanobromide
cyanogen bromide (brcn)
nsc-89684
bromocyanogen
506-68-3
campilit
bromocyanide(brcn)
nsc89684
bromocyanide
cyanogen monobromide
bromine cyanide(brcn)
tl 822
bromocyan
bromure de cyanogen
bromine cyanide
cyanogen bromide
cyanic bromide
einecs 208-051-2
hsdb 708
rcra waste number u246
bromocyane
nsc 89684
ai3-28715
brn 1697296
rcra waste no. u246
cyanogen bromide ((cn)br)
bromure de cyanogen [french]
un1889
cyanogen bromide, 99.995% trace metals basis
cyanogen bromide, reagent grade, 97%
cyanogen bromide, >=98.5% (rt)
bromoformonitrile
carbononitridic bromide
FT-0665252
AKOS009152676
cyanogen bromide [un1889] [poison]
os382ohj8p ,
4-03-00-00092 (beilstein handbook reference)
unii-os382ohj8p
BP-10442
cyanogen bromide [hsdb]
cyanogen bromide [mi]
bromcyane
cnbr
br-cn
bromo cyane
cyanogenbromide
brcn
bromocyanide (brcn)
bromine monocyanide
un 1889
bromine cyanide (brcn)
(cn)br
cyanic bromide #
NCGC00356964-01
tox21_303779
dtxcid601550
cas-506-68-3
dtxsid9021550 ,
CHEMBL3561885
mfcd00011597
J-520130
J-802176
Q420258
cyanogen-13c bromide

Research Excerpts

Overview

Cyanogen bromide (CNBr) is a common chemical used to hydrolyze peptide bonds C-terminal to methionine residues.

ExcerptReferenceRelevance
"Cyanogen bromide (CNBr) is a common chemical used to hydrolyze peptide bonds C-terminal to methionine residues in peptides and proteins. "( Enhancement of cyanogen bromide cleavage yields for methionyl-serine and methionyl-threonine peptide bonds.
Kaiser, R; Metzka, L, 1999
)
2.1
"Cyanogen bromide was found to be a highly effective reagent for the coupling of oligoadenylates on a polyuridylic acid template in aqueous solution. "( Template-directed synthesis of oligoadenylates using cyanogen bromide and diiminosuccinonitrile.
Kanaya, E; Yanagawa, H, 1985
)
1.96

Effects

ExcerptReferenceRelevance
"Cyanogen bromide has been found to induce the template-guided condensation of oligonucleotides only in the presence of N-substituted morpholines. "( Derivatization and template-guided ligation of oligodeoxyribonucleotides using cyanogen bromide and N-substituted morpholines.
Dolinnaya, NG; Fedorova, OA; Gottikh, MB; Shabarova, ZA, 1997
)
1.97

Treatment

Cyanogen bromide (CNBr) treatment then released amines into solution. Treatment of bovine nasal cartilage proteoglycan monomer gave rise to three major fractions (CN-1 to CN-3), isolated by Sepharose CL-6B chromatography.

ExcerptReferenceRelevance
"Cyanogen bromide (CNBr) treatment then released amines into solution."( A convenient orthogonally cleavable methionine handle for anchoring amines to polymeric supports.
Barany, G; Kappel, JC,
)
0.85
"Cyanogen bromide-treated fibrinogen (50 microg/ml) gave a 10-fold enhancement of activation by itself, and addition of 2.86 microg/ml oversulfated compounds amplified this to 15-fold."( Effect of oversulfated chondroitin-6-sulfate or oversulfated fucoidan in the activation of glutamic plasminogen by tissue plasminogen activator: role of lysine and cyanogen bromide-fibrinogen.
Anderson, D; Carranza, YE; Doctor, V, 2008
)
1.26
"Cyanogen bromide treatment of bovine nasal cartilage proteoglycan monomer gave rise to three major fractions (CN-1 to CN-3), isolated by Sepharose CL-6B chromatography. "( Identification of cyanogen bromide-fragments of the protein core of bovine nasal cartilage proteoglycan monomer.
Bonnet, F; Jollès, J; Jollès, P; Le Glédic, S; Périn, JP, 1983
)
2.04
"Cyanogen bromide treatment of the glycoprotein resulted in four peptides with molecular weights of 18 000, 12 000, 5000 and 1000, three of the peptides containing hydroxyproline and two of the peptides containing carbohydrates."( Structural studies on a collagen-like glycoprotein isolated from lung lavage of normal animal.
Bhattacharyya, SN; Lynn, WS, 1980
)
0.98
"Cyanogen bromide treatment of reduced, S-carboxymethylated phosphoglycerate kinase yielded 14 major peptides, CNBr-1 (20 residues), CNBr-2 (8 residues), CNBr-3 (33 residues), CNBr-4 (11 residues), CNBr-5 (104 residues), CNBr-6 (14 residues), CNBr-7 (37 residues), CNBr-8 (7 residues), CNBr-9 (6 residues), CNBr-10 (11 residues), CNBr-11 (19 residues), CNBr-12 (42 residues), CNBr-13 (44 residues), and CNBr-14 (61 residues). "( Complete amino acid sequence of human phosphoglycerate kinase. Cyanogen bromide peptides and complete amino acid sequence.
Huang, IY; Welch, CD; Yoshida, A, 1980
)
1.94
"Cyanogen bromide treatment of the intact receptor produces a 23.4 kDa (theoretical) fragment consisting of residues 108-324 and containing all of the identified phosphorylated serines within the receptor."( Localization of the approximately 12 kDa M(r) discrepancy in gel migration of the mouse glucocorticoid receptor to the major phosphorylated cyanogen bromide fragment in the transactivating domain.
Dalman, FC; Groner, B; Hoeck, W; Hutchison, KA; Pratt, WB, 1993
)
1.21
"Cyanogen bromide (CNBr) treatment of native CS-Act produced three major and several minor peptide fragments."( Porcine cerebroside sulfate activator: further structural characterization and disulfide identification.
Conklin, KA; Faull, KF; Fluharty, AL; Green, BN; Stevens, RL, 1993
)
1.01
"Cyanogen bromide-treated pilus preparation might have potential as a vaccine because antibodies are induced against heterologous strains of M."( Immunoblot analysis of cyanogen bromide-cleaved Moraxella bovis pilin reveals presence of shared antigenic determinants on pili from heterologous strains.
Greene, WH; Grubbs, ST; Potgieter, LN, 2001
)
1.34
"Cyanogen bromide (CNBr) treatment of the glycoprotein resulted in four peptides with molecular weights of 36,000, 27,000, 12,000, and 5,000."( Structural characterization of a glycoprotein isolated from alveoli of patients with alveolar proteinosis.
Bhattacharyya, SN; Lynn, WS, 1979
)
0.98
"Cyanogen bromide treatment of thymidylate synthetase of Lactobacillus casei, which had been converted to a ternary complex with [2-14c] FdUMP and 5,10-methylene-tetrahydrofolate followed by S-carboxymethylation, yielded at least four visible peptide bands, the largest with a molecular weight of about 13,000, on polyacrylamide gel electrophoresis in sodium dodecyl sulfate-urea. "( Amino acid sequence at the FdUMP binding site of thymidylate synthetase.
Bellisario, RL; Galivan, JH; Maley, F; Maley, GF, 1976
)
1.7
"Cyanogen bromide (CNBr) treatment of the glycoprotein resulted, as expected, in four peptides of apparent molecular weights of 18 000, 12 000, 5000 and 1000, respectively."( Structural studies on a glycoprotein isolated from alveoli of patients with alveolar proteinosis.
Bhattacharyya, SN; Lynn, WS; Sahu, S, 1976
)
0.98
"Cyanogen bromide treatment of the oxidized glycophorin yielded fragments showing that the only methionine residue oxidized by ozone was residue 8."( Reaction of ozone with glycophorin in solution and in lipid vesicles.
Banerjee, SK; Mudd, JB, 1992
)
1
"Cyanogen bromide treatment of albumin out of the goiter and of serum albumin gave comparable cleavage patterns, indicating that no great differences in amino acid composition, especially methionine, exist."( Thyroid albumin originates from blood.
de Vijlder, JJ; van Dijk, JE; Veenboer, GJ, 1992
)
1
"Cyanogen bromide treatment of the partially purified protein produced a major labeled peptide of 14 kDa with an NH2-terminal sequence 90% identical to a region of form 1 rabbit liver microsomal carboxylesterase."( A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases.
Chapman, HA; Chin, DT; Gerard, C; Mark, EA; Munger, JS; Shi, GP, 1991
)
1
"Cyanogen bromide treatment generated a 13,000 MW major fragment from both SMBP and GABA-modulin."( GABA-modulin: a synaptosomal basic protein that differs from small myelin basic protein of rat brain.
Costa, E; Guidotti, A; Panula, P; Tronconi, BM; Vaccarino, F, 1985
)
0.99
"On treatment with cyanogen bromide, these proteins gave three classes of peptides with molecular weights of 30,000, 10,000, and smaller than or equal to 5,000."( The structure of rat proalbumin.
Geller, DM; Russell, JH, 1975
)
0.58
"Upon treatment with cyanogen bromide they yield small heme-containing peptides of highly similar amino acid composition."( Immunochemical and compositional comparison of cytochrome P-450 cam of Pseudomonas putida and P-450 lm of phenobarbital-induced rabbit liver microsomes.
Dus, K; Litchfield, WJ; Miguel, AG, 1975
)
0.57

Toxicity

ExcerptReferenceRelevance
"The complete amino-acid sequence of ammodytoxin B, a presynaptically toxic phospholipase A2 isolated from Vipera ammodytes ammodytes venom, was determined by manual and automated protein sequencing."( Amino-acid sequence of ammodytoxin B partially reveals the location of the site of toxicity of ammodytoxins.
Gubensek, F; Machleidt, W; Ritonja, A; Turk, V, 1986
)
0.27

Compound-Compound Interactions

ExcerptReferenceRelevance
" We present a sequential CNBr and trypsin in-gel digestion method combined with mass spectrometry for membrane protein analysis."( Development and applications of in-gel CNBr/tryptic digestion combined with mass spectrometry for the analysis of membrane proteins.
Keller, BO; Li, L; Li, N; Quach, TT; Richards, DP; Zheng, J,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves of platelet aggregation induced by alpha 1 and the binding of alpha 1 by platelet membranes correlate closely."( Binding of chick skin collagen alpha 1 chain by isolated membranes from human platelets.
Chiang, TM; Kang, AH, 1976
)
0.26
" Oral administration of a high dosage of CB11 provided partial protection from chondritis."( Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease.
Barbieri, M; Cheng, KC; Kim, N; Kwon, SS; Mora, R; Yoo, TJ, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency72.65380.000714.592883.7951AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159552
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency76.95880.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4,289)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903090 (72.04)18.7374
1990's929 (21.66)18.2507
2000's220 (5.13)29.6817
2010's46 (1.07)24.3611
2020's4 (0.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 69.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index69.68 (24.57)
Research Supply Index8.38 (2.92)
Research Growth Index3.92 (4.65)
Search Engine Demand Index126.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (69.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.05%)5.53%
Reviews41 (0.94%)6.00%
Case Studies20 (0.46%)4.05%
Observational0 (0.00%)0.25%
Other4,307 (98.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]